Author: aktnadmin

A large-scale clinical trial finds lanthanum carbonate does not reduce the risk of cardiovascular disease developing in patients with chronic kidney disease.The drug is routinely

We are delighted to announce that recruitment for BEST-Fluids is now complete, with 808 participants enrolled. Congratulations to all the study teams for your hard

Let’s hear the patient voice Are you a patient or carer who would like to be involved in how clinical trials are designed? We’d love

The IMPEDE-PKD and M-FIT trials have been successful in receiving funding via the Medical Research Future Fund (MRFF) rare cancers, rare diseases and unmet needs

A major clinical trial run by the AKTN finds the drug allopurinol does not prevent worsening of kidney disease.  University of Queensland researchers at the

Is Plasmalyte or Saline best for preventing DGF in kidney transplantation? BEST-Fluids is a pragmatic registry trial that will answer this. Protocol has now been